Coronavirus in Mumbai: BMC to give hydroxychloroquine tablets to those at risk of contracting COVID-19 in slum pockets

Coronavirus in Mumbai: BMC to give hydroxychloroquine tablets to those at risk of contracting COVID-19 in slum pockets

BMC sources said the civic administration had taken a decision to distribute HCQ pills to those living in Dharavi and in COVID-19-affected parts of Worli, who are healthy and do not have underlying co-morbidities such as diabetes or hypertension

Vikas NagUpdated: Thursday, April 16, 2020, 07:26 AM IST
article-image
The HCQ tablets will be given to healthy citizens between the ages of 18 and 55 | Kunal Patil

Mumbai: Mumbai Mayor Kishori Pednekar on Tuesday confirmed to The Free Press Journal that, as a preventive medication or prophylaxis, the BMC has decided to distribute hydroxychloroquine (HCQ) tablets to healthy people who are at risk of contracting COVID-19 as they live in hotspots in the city, such as the slums of Dharavi and Worli Koliwada.

"So far, patients who have recovered from the coronavirus disease were given the hydroxychloroquine tablet with vitamin C tablet. If the drug is taken by those at risk of contracting the infection, then it reduces the risk to the person taking it even if the disease spreads. A decision has been taken by the BMC to soon distribute hydroxychloroquine tablets in some hotspots identified in the city", Pednekar said.

The HCQ tablets will be given to healthy citizens between the ages of 18 and 55. BMC sources said the civic administration had taken a decision to distribute HCQ pills to those living in Dharavi and in COVID-19-affected parts of Worli, who are healthy and do not have underlying co-morbidities such as diabetes or hypertension.

The drug will be administered for seven weeks. In the first week, two pills will be given, and thereafter one pill for each remaining week, sources said. (HCQ) is an anti-malarial drug that has shown to have shortened the duration for clinical recovery in case of some Covid-19 patients.

However, these results have only been displayed in small lab-controlled tests. It’s efficacy in treating Covid-19 or as prophylaxis is yet to be conclusively established.

The Indian Council for Medical Research (ICMR) has cleared HCQ to be used as a prophylaxis by doctors, nurses and other health staff. The Union Health Ministry recently placed the drug under Schedule H1, which can be sold on prescription only.

U.S. President Donald Trump has called the drug a game changer in the fight against COVID-19. He had warned India of "retaliation’’" if it did not revoke the ban on its export. Notably, India had earlier allowed the export of the drug to 13 countries, including the US before putting a ban on all exports except for neighbouring SAARC countries that depended on India.

RECENT STORIES

Western Railway To Run 3 Pairs Of Summer Special Trains To Various Destinations To Meet Travel...

Western Railway To Run 3 Pairs Of Summer Special Trains To Various Destinations To Meet Travel...

Mumbai: Indian Railways Extend Services Of LTT-Gorakhpur Summer Special Trains By Additional 30...

Mumbai: Indian Railways Extend Services Of LTT-Gorakhpur Summer Special Trains By Additional 30...

Mumbai: NCDRC Rejects Claim Of Dhariwal Industries Siting Compensation For Loss of 350 Cartons Of...

Mumbai: NCDRC Rejects Claim Of Dhariwal Industries Siting Compensation For Loss of 350 Cartons Of...

Mumbai News: Commuters Struggle Despite Traffic Police Takes Action Against Over 50,000...

Mumbai News: Commuters Struggle Despite Traffic Police Takes Action Against Over 50,000...

Mumbai: Car Owners Raise Concerns Over Illegal Parking And Chaotic Traffic, Says Park+ App Survey...

Mumbai: Car Owners Raise Concerns Over Illegal Parking And Chaotic Traffic, Says Park+ App Survey...